Towards a public European health infrastructure
‘A revolution is needed in the EU pharma ecosystem’, written by Luisa Antunes, Scientific Foresight Unit (STOA).
The proposal for a public European health infrastructure builds upon a Parliament resolution of 17 September 2020, calling on the Commission and Member States to “examine the possibility of creating one or more European non-profit pharmaceutical undertakings which operate in the public interest to manufacture medicinal products of health.” On December 2021 Council conclusions also took note of the importance of the Parliament’s resolution to ensuring the supply of medicinal products affected by market failures. More recently, in July 2022, the study was the object of an open letter to the EU institutions and governments, signed by researchers, medical professionals and health ministers, calling for the creation of a public European infrastructure that can develop vaccines and other therapeutics, for the common good. The project is now expected to be discussed in Parliament’s Committees Environment, Public Health and Food Safety (ENVI), Industry, Research and Energy (ITRE) and Special Committee on COVID-19 Pandemic: Lessons Learned and Recommendations for the Future (COVI).
Click here to read the full article.